Good Questions Create Clarity
Having conversations regarding how C-suite leaders consider their compliance in the dietary supplement and food and beverage industries, is common practice for consultants and counsel that routinely provide regulatory support and guidance in FDA (U.S. Food and Drug Administration) matters. We recently had a very interesting conversation on what compliance actually protects for any business in the dietary supplement industry. While we bring different perspectives to the question, one of us being an attorney and the other a consultant, our many years working in the industry lead us to the same endpoints: Size doesn’t matter; commitment does. Our conversation focused on our mutual involvement that over the expanse of our experience, we had discovered that many industry leaders frequently failed to focus on the value of regulatory and compliance information. At this level, they want clear, direct interpretation that relates to the bottom line. What matters is understanding what protects, what sustains, and what ultimately determines whether the business succeeds or fails. It’s the smart leaders in the industry who are the ones that are prepared to see more and see before and treat compliance as a proactive strategic, front‑end investment instead of a back‑end cost. To this end, we believe that it is imperative to consider two high-level questions: If you fail to invest in your company’s compliance, what will your corporate income go to? And how do you place real-time value on company reputation?
These questions are not rhetorical. They are structural. They define how operational discipline (compliance) connects to market trust and financial continuity in an industry that offers consumers goods that are represented as biologically active and beneficial for public health. In FDA-regulated industries where visibility is high and tolerance for error is low, these are not abstract considerations. They are real, operating conditions that surface quickly when systems are tested, inspected or exposed. This is especially evident across the dietary supplement and food and beverage sectors, where quality systems, product specifications and operational processes are continuously under FDA scrutiny, and frequently found to be wanting. Review of the warning letters posted every Tuesday morning on the FDA website is evidence to this.
Compliance As the Key Continuity Factor
Compliance is a legal requirement, but at times it is often addressed as a cost to be tightly managed. Many C-suite officers consider it “mere overhead” that does not generate profit; a drain on resources that could be spent on marketing. That perspective is risky because compliance is not separate from the business. It is an essential requirement that is part of the law under which the supplement industry exists. It is what allows the business to continue. When compliance systems are properly established and functioning as intended, products remain on the market, distribution stays undisrupted, and consumer trust remains unbroken. This is visible not only through regulatory outcomes but also in customer response and market feedback.
When Compliance Fails
However, when these systems fail, the impact is not gradual. It is immediate, visible and consequential. Not only is operational continuity disrupted, but workforce confidence becomes strained, and leadership attention is diverted to crisis management. More importantly, the brand itself becomes exposed to reputational vulnerability, where restoring trust with customers can prove far more difficult than maintaining that trust through compliance in the first place. Critical violations and regulatory actions quickly become public and directly impact your business. They result in FDA Form 483 observations that can quickly escalate to FDA warning letters and often remain in that public domain indefinitely. Brand confidence, once disrupted, does not decline quietly; it shifts behavior across customers, contract partners and stakeholders in real time; and in these times of digital communication, the effects extend rapidly across social media and the supply chain, creating immediate negative repercussions that are both operational and financial. Derogatory information once present on the internet can be extraordinarily difficult to remove.
This is where the first question makes things clear: If you invest in your compliance, your corporate income doesn’t go to zero dollars.
It is not about cost avoidance. It is about preventing interruption of your business on a scale that may be impossible to recover from, and from being under unnecessary regulatory scrutiny of the kind that can create uncertainty amongst your consumers, businesses partners and even your staff.
Reputation As a Key Financial Force
Reputation introduces a different, but equally important, aspect. It is often labeled as intangible, difficult to assign a precise value to, but in practice, reputation can be the most valuable asset a company possesses. The challenge is not that reputation lacks value, but rather its value is distributed across decisions, relationships and outcomes that do not appear as a single line item written on an invoice or corporate balance sheet. Its measure is reflected in several notable things such as sustained customer demand, long-standing supply chain partnerships, consistent acceptable federal inspection outcomes, and continued commitment from investors and stakeholders. It is reflected in how quickly an issue escalates or how effectively it is contained. It influences whether a situation remains manageable or becomes a defining moment for your business.
A more useful perspective for leadership is not to ask what reputation is worth, but to understand what is at risk if it is lost. What portion of the business becomes vulnerable when trust is compromised? How quickly does that vulnerability translate into operational or financial impact? How difficult is it to restore reputation once it is lost? As former U.S. Secretary of Labor Raymond Donovan asked following his acquittal by a jury on federal charges of corruption, “Which office do I go to get my reputation back?”
As earlier noted, when compliance fails and trust is disrupted, the effects are not conceptual. They are tangible, immediate and far-reaching. Activities across the organization, from procurement to contractual relationships, come under increased scrutiny. Regulatory attention intensifies. Internal company stability is shaken. Recovery, in these situations, is rarely immediate. It requires time, consistency and documented evidence—often a substantial amount. And in nearly every case, rebuilding compliance, brand and market trust demands more than maintaining it ever would have. Which brings clarity to the second question: Company reputation is not defined by a fixed financial value; it is revealed through consequential outcomes.
A Clear Leadership Perspective
At the executive leadership level, there is often an assumption that speed to market is constrained by compliance. However, this is a perspective that will inevitably be challenged. In the dietary supplement industry that will most likely be the moment the company faces the test of an unannounced FDA inspection or an unexpected costly product recall. When ownership and leadership support are absent, risk becomes a more imminent reality than a likely possibility. Even robust quality management systems weaken when organizational focus and priorities shift, accountability fragments, and leadership engagement decline or become non-existent. The consequence extends beyond procedural gaps, exposing the organization’s operations, workforce uncertainty, and ultimately its reputation. Operating under FDA oversight requires that compliance must therefore be sustained as a core leadership responsibility, supported with the same discipline applied to financial performance and strategic growth.
Business operations that are not supported by strong regulatory and compliance systems create significant financial risk. Conversely, the companies most likely to experience successful business continuity are those that do not minimize compliance investment. They recognize this investment as essential to business continuity, brand protection, ensuring continued commitment from investors and supply chain partners, and how the company is evaluated in the market. As a leader, you may never be able to assign precise monetary value to your company’s reputation, but you will experience its financial impact, especially when it is under pressure. You will see the results of your compliance decisions, whether in continuity or interruption.
Investing in your compliance as a means of valuing your company’s reputation is a recognition of how regulated businesses must function under the law. While the cost of compliance may appear on the balance sheet, reputation does not appear as a single figure, but in many cases, both determine whether the figures on that balance sheet hold. NIE
Heather Fairman is a highly sought-after industry thought leader, speaker, and consultant on U.S. Food and Drug Administration (FDA) regulatory and compliance matters. https://dfguardianconsulting.com/ Marc S. Ullman of Counsel Rivkin Radler represents clients in matters relating to all aspects of FDA regulatory issues with a focus on the dietary supplement/natural products industry www.rivkinradler.com/attorneys/marc-ullman/.
